Andrew E. Epstein MD, FAHA, FACC, FHRSProfessor of Medicine, Hospital of the University of Pennsylvania and Veteran's Administration Medical Center, Philadelphia, Pennsylvania
Andrew E. Epstein, MD is Professor of Medicine, Cardiovascular Division, at the University of Pennsylvania, and Chief of the Cardiology Section at the Philadelphia VA Medical Center. He graduated from Amherst College in 1973 and the University of Rochester School of Medicine and Dentistry in 1977. After completing his internship and residency in internal medicine at Washington University/Barnes Hospital, Dr. Epstein went to the University of Alabama, where he completed his fellowship in cardiovascular medicine and joined the faculty in 1982. He remained there until 2009 when he was recruited to Philadelphia. He is board certified in Internal Medicine, Cardiology, and Clinical Cardiac Electrophysiology.
Dr. Epstein is a fellow of the American College of Cardiology, the Council on Clinical Cardiology of the American Heart Association, and of the Heart Rhythm Society. For the American Heart Association he has served as chairman of its committees on Sudden Cardiac Death and on Electrocardiography and Arrhythmias. He is currently Co-chair of the ACC/AHA/HRS Guideline Committee for the implantation of cardiac pacemakers and antiarrhythmic devices. In 2012 he was elected to the Association of University Cardiologists. His teaching awards at the University of Alabama at Birmingham include a "10 Best Teachers" award from the Department of Medicine in 1998 and 2008, the Cobbs-Rutsky Clinical Excellence Award from the Department of Medicine in 2006, and the H. Cecil Coghlan Teaching Excellence Award for the Division of Cardiovascular Disease in 2006.
Dr Epstein's research interests lie in the management of atrial and ventricular arrhythmias. He has been involved in numerous clinical trials, having chaired the recruitment committees for the NIH/NHLBI-sponsored Cardiac Arrhythmia Suppression Trial (CAST), the Antiarrhythmics versus Implantable Defibrillators (AVID) Study, the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study, and the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. He has authored several hundred papers, abstracts, book chapters, and reviews and has edited two books. He serves on the editorial boards of the Journal of Cardiovascular Electrophysiology (Senior Associate Editor), Journal of Interventional Cardiac Electrophysiology (Associate Editor), Heart Rhythm, PACE, Journal of Innovations in Cardiac Rhythm Management, Cardiology Today and the American Journal of Cardiology.
Honoraria: Biotronik, Boston Scientific, Medtronic, St. Jude Medical
Research Support: Biotronik, Boston Scientific, Medtronic, St. Jude Medical
Fellowship Support: Biotronik, Boston Scientific, Medtronic, St. Jude Medical
Recent Contributions to PracticeUpdate:
- Initial Precipitants and Recurrence of Atrial Fibrillation
- ICDs in Non-Ischemic Cardiomyopathy Patients Reduce Mortality Only in the Presence of Left Ventricular Scar
- Prognostic Value of Non-Inducibility on Outcomes of Ventricular Tachycardia Ablation
- Management of Ventricular Arrhythmias and Prevention of Sudden Cardiac Death
- Mid-Wall Late Gadolinium Enhancement Predicts Sudden Cardiac Death in Dilated Cardiomyopathy
- Novel Implantable Cardioverter Defibrillator Programming and Inappropriate Implantable Cardioverter Defibrillator Therapy
- Improvement in QoL After Catheter Ablation for Atrial Fibrillation
- Incidence and Predictors of Right Ventricular Pacing–Induced Cardiomyopathy
- Optimal LVEF for Risk Stratification for Cardiac Death